Relmada a Leader in Clinical Stage Drugs

Relmada Therapeutics, a medical company that primarily deals with the development of clinical-stage therapies that we manufactures for the treatment of chronic illness. Recently we made an announcement that was purposely meant to make amendments to the complaints that we had filed against Laidlaw & Company (UK Ltd), in a United States District court for the District of Nevada. As Relmada we are filling the motion as part of a previous law suit that we had filed in the Nevada District Court. Part of the amendment that we filed included the breach of fiduciary duty that Laidlaw acquired when it disclosed some our company’s confidential information when it was acting as our investment bank.
The management of Relmalda noticed that the District Court of Nevada had issued a temporary injunction as well as a restraint order to the principals of our investment bank Mathew Eitner and James Ahern. The court had issued the order as a result of the damages that the investment company had caused our organization by distributing false as well as misleading materials. Our management team believes that Laidlaw must compensate us for the damages it has caused our company and must be prevented from harming our organization in the future.
Laidlaw & Company UK Ltd is an investment company that has a primary mandate of offering banking and investment solutions as well as services to its wide range of customers include individuals, and corporate institutions. The company has its operations conducted in the United States as well as the United Kingdom. The Laidlaw offers a broad range of services and products to its clients including placement of equity, placement of debt, acquisition financing, institution investment, the arrangement of national exchange listing, initial public offering, as well as entresol capital with institutional investors.
The company has a well able leadership that include James Ahern who serves as the Managing Partner and the Head of Capital Markets. Mathew Eitner has also been part of the management team at Laidlaw & Company and has been acting in the position of the Chief Executive Officer.